corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13660

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Pfizer to disclose grants to increase transparency
Pharma Times 2008 May 15
http://www.pharmatimes.com/WorldNews/article.aspx?id=13496&src=EWorldNews


Full text:

A day after Eli Lilly stated its support for the revised Physician Payments Sunshine Act about declaring gifts to doctors, Pfizer has announced that it is posting a list of grants and charitable contributions made in the first quarter.

The New York-based drugs giant says that the move, which follows a similar policy adopted by Lilly last year, is “part of an ongoing drive throughout the company to increase transparency”. Of $9.97 million given out to 242 US medical, scientific and patient organisations in the first quarter of 2008, the largest grant, one of over $3.4 million, was made to the California Academy of Family Physicians in March for “ a three-year national health care professional education campaign to reduce the number of US smokers”. Pfizer markets the smoking cessation treatment Chantix (varenicline).

Chief executive Jeff Kindler said that “detailing these grants and charitable contributions is an important part of our ongoing transparency drive.” Pfizer also noted that it began disclosing political contributions and registering clinical trials in 2002 and in 2006 launched a regularly updated public site describing compounds under development and their progress. Last year, it began reporting its post-marketing commitments to the US Food and Drug Administration relating to the safety, efficacy or the use of its medicines.

The issue of transparency is under the spotlight again with the updated version of Sunshine Act which is due to come into force at the end of March 2011. Lilly has backed the changes which raises the payment limit requiring disclosure from $25 to $500, while possible fines have been reduced to $1,000-$50,000 from $10,000-$100,000 for each violation.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909